Screener
USANA Health Sciences USNA Hiya — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Core Nutritional | Hiya | Rise | Total |
|---|---|---|---|---|
| Net sales (1) | $204,399 | $32,150 | $13,669 | $250,218 |
| Less: | ||||
| Cost of sales | 36,749 | 9,983 | 12,704 | 59,436 |
| Brand Partner incentives | 88,654 | — | — | 88,654 |
| Selling, general and administrative (2) | 60,747 | 24,771 | 2,736 | 88,254 |
| Segment earnings (loss) from operations | $18,249 | $(2,604) | $(1,771) | $13,874 |
| Reconciliation of segment earnings from operations | ||||
| Interest income | 437 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's hiya — net sales?
- USANA Health Sciences (USNA) reported hiya — net sales of $32.15M in Q1 2026.
- How has USANA Health Sciences's hiya — net sales changed year-over-year?
- USANA Health Sciences's hiya — net sales decreased by 13.3% year-over-year, from $37.09M to $32.15M.
- What does hiya — net sales mean?
- Represents the total revenue generated from the sale of products or services within the Hiya business segment after deductions for returns, allowances, and discounts. This metric serves as a primary indicator of the segment's market demand and top-line growth performance. It is essential for evaluating the contribution of this specific business unit to the company's overall consolidated revenue.
Ask your AI about USANA Health Sciences's hiya — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude